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Abstract 
Background: both serum albumin and total cholesterol are potential markers of frailty. A decline in functional status is one
of the key components of frailty. 
Objective: the aim of this study was to investigate the association of serum albumin and total cholesterol, separately and
combined, with future decline in functional performance. 
Design: the Longitudinal Aging Study Amsterdam, an ongoing population-based longitudinal study, started in 1992/1993
with a follow-up every 3 years. 
Participants: 1,064 men and women aged 55–85 years with complete data on serum albumin and total cholesterol at baseline,
and functional performance at baseline and 3-year follow-up. 
Measurements: at baseline, serum albumin and total cholesterol were measured. At baseline and 3 years later, decline in
functional status was measured with three performance tests (chair stand, 3-metre walk, putting on and taking off a cardigan).
Associations were adjusted for age, life-style and health-related factors. 
Results: albumin concentration was not associated with decline in functional performance in men and women. Women with
lower serum total cholesterol concentration (≤5.2 mmol/l) were more likely to decline in functional status compared to
women with higher serum total cholesterol concentration (reference; OR = 2.50; 95% CI 1.07–5.84). Men with lower serum
albumin (≤43 g/l) and lower serum total cholesterol concentration were three times more likely to decline in functional
performance compared to men with higher levels (OR = 3.00; 95% CI 1.00–8.97). In women, a similar trend was found
(OR = 1.73; 95% CI 0.34–8.94), although not statistically signiWcant. 
Conclusions: a combination of low albumin and low cholesterol levels may increase the risk of future functional decline. 
Keywords: serum albumin, serum cholesterol, functional status, performance test, frailty, elderly, longitudinal 
Introduction 
For the ageing population, frailty is nowadays a commonly
used concept, but no standardised deWnition has yet been
established. It is clear that frailty is not solely a result of the
deterioration of one single system, but multiple systems
such as musculoskeletal, cardiovascular, metabolic or immuno-
logical systems [1–3]. Frail persons are considered to be at
risk for morbidity and mortality [4]. One way in which frail
persons can be identiWed is by screening several systems
together, and another way is by using biochemical markers.
Both serum albumin and total cholesterol levels might be
possible markers of frailty [5]. 
Serum albumin is the main protein synthesised by the
liver. This protein maintains osmotic pressure and transports
various substances through the bloodstream [6]. Total
cholesterol is a lipid or fat, and is synthesised in many types of
tissue, but particularly in the liver and intestinal wall. Approx-
imately three-quarters of cholesterol is synthesised in the
body, and one-quarter originates from dietary intake [7]. 
Previous studies have investigated serum albumin and total
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studies have reported an association between hypoalbuminae-
mia and self-reported functional status in community-dwelling
older persons. Hypoalbuminaemia, serum albumin levels of
<35 g/l, was associated with two or more limitations in activ-
ities of daily living (ADL) [8] and with impaired functional
status, deWned as having at least one self-reported ADL
limitation [9]. 
Four studies focused on the association of albumin or
total cholesterol with longitudinal change in functional status.
The Wrst study showed that low serum albumin levels were
associated with a decline in self-reported functioning during
a 2-year follow-up in older disabled nursing home residents [10].
The second study found that low serum albumin (<38 g/l)
was associated with 3-year and not with 7-year functional
decline in high-functioning older persons [11]. The third
study found that persons in the lowest tertile of total cholesterol
had an increased risk for decline in self-reported function
during a 2-year follow-up compared to those in the highest
tertile [12]. The fourth study found combined levels of
lower serum albumin and lower serum total cholesterol con-
centration to be associated with an increased risk for 3-year
change in self-reported functional decline [13]. Nevertheless
this association was not adjusted for potential confounders. 
These prospective studies were carried out in either low
or high functioning groups, but not in a population-based
cohort. Whether serum albumin and total cholesterol are
early markers for functional decline, based on performance-
based tests, has not yet been investigated. Furthermore, the
study that combined serum albumin and total cholesterol
levels reported unadjusted results. Tests of functional per-
formance are a more objective measurement for decline in
functional status than self-reports [10, 12–14]. 
In the Longitudinal Aging Study Amsterdam (LASA), a
population-based study among 3,107 men and women aged
55–85 years, functional status was measured with three per-
formance tests. These tests were repeated every 3 years to
assess the longitudinal change in functional status. Further-
more, many potentially confounding variables were taken
into account. The aim of this study was to investigate the
association between serum albumin, total cholesterol, and
combined serum albumin and total cholesterol levels, with
future decline in functional performance in population-
based older persons. 
Methods 
Study sample 
The data presented were collected in the context of the
LASA, which is an interdisciplinary longitudinal study that
focuses on changes in physical, cognitive, emotional and
social functioning in older persons. Details of LASA are
described elsewhere [15, 16]. BrieXy, a random sample
stratiWed for age and sex was drawn from the population
registers of 11 municipalities in three regions (West, North-
east and South) of the Netherlands. Each area consists of
one middle- to large-size city and two or more rural munici-
palities that border on the city. To ensure sufWciently large
numbers in all cells 5 years into the study, the numbers of
males and females in each age category were weighted using
survival rates. In 1992, at baseline, LASA started with
3,107 respondents, aged 55–85 years, 1,506 men and
1,601 women. Data were collected in a face-to-face main
interview, which was carried out at the subject’s home and
by specially trained interviewers. Two to six weeks later the
main interview was followed by a medical interview, during
which a nurse-interviewer collected blood samples if informed
consent was obtained. The same data-collection procedures
were carried out after 3 years. The Medical Ethics Committee
of the Academic Hospital of the VU University Medical
Center approved this study. 
Of the 3,107 respondents who participated in the LASA
main baseline interview (response rate 81.7%), 2,671 partic-
ipated in the medical interview. No blood samples were col-
lected in the South region (n = 661) or in part of the West
region (n = 498). Blood samples from 5 respondents were
not analysed. As a consequence, complete data on albumin
and total cholesterol concentration were available for
1,507 LASA respondents. Respondents were excluded when
they had been taking cholesterol-lowering medication (n=23)
or when they had no complete data on functional perform-
ance at baseline (n = 84) or at 3-year follow-up (n = 336). Of
the latter 336 respondents, 144 had died, 26 refused, 11 were
ineligible to be interviewed, 8 could not be contacted and
147 had no complete data on the performance tests. 
In total, the present study sample consisted of 1,064
(70.6%) older persons, 515 men and 549 women. Com-
pared to those who were excluded (29.4% of the respond-
ents with measures of serum total cholesterol and albumin),
the respondents in the present study sample (n = 1,064) had
fewer depressive symptoms, a better cognitive status, a
higher level of education, a higher overall baseline perform-
ance score, a higher serum albumin concentration, were
younger, were more often of female gender, drank more
often 2 glasses or more per day, and reported less often the
presence of diabetes, CVA (cerebrovascular accident), heart
disease or cancer at baseline [Appendix 1 (available as
supplementary data at http://www.ageing.oupjournals.org),
P < 0.05]. 
Blood markers 
Blood was collected in a non-fasting state, in a sitting position.
Serum samples were obtained and analysed directly. The
analyses were carried out in two laboratories in the Netherlands.
Serum albumin concentrations were determined by using a
bromcresol green (BCG) dye-binding method. Total cholesterol
was measured by enzymatic colorimetry assay with a Hitachi
747 analyser. The clinically accepted cut-off point for low
albumin is 38 g/l. Since only one person had an albumin
level below 38 g/l, 43 g/l was used as the cut-off point for
lower albumin [17]. Only 20 persons (1.9%) of the sample
had a total cholesterol level lower than 4.1 mmol/l, the
commonly used cut-off point of serum total cholesterol.
Therefore the cut-off point used for lower serum total cho-
lesterol was 5.2 mmol/l [18]. Thus, subjects were classiWed
into two serum albumin categories (≤43 g/l and >43 g/l)
and into two serum total cholesterol categories (≤5.2 mmol/l
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Performance tests 
Performance-based tests have been used in several recent
studies and have been found to be a good objective indicator
of physical function [19–21]. In LASA, at baseline and at 3-year
follow-up performance-based tests were carried out. These tests
included walking, repeated chair stands, and putting on and
taking off a cardigan [20, 22]. Each test was timed, and
scored according to quartiles based on the LASA cohort at
baseline [23]. For the walking test, the participants were asked
to walk 3 metres, to turn around and to walk back 3 metres
as quickly as possible and were categorised: unable (0); ≥10
seconds (score 1); 8–9 seconds (score 2); 7 seconds (score 3);
and ≤6 seconds (score 4). For the repeated chair stands, par-
ticipants were asked to fold their arms across their chest and
to stand up Wve times from a kitchen chair. This test was cate-
gorised: unable (0); ≥15 seconds (score 1); 12–14 seconds
(score 2); 10–11 seconds (score 3); and ≤9 seconds (score 4). The
time to put on and take off a cardigan was categorised:
unable (0); ≥15 seconds (score 1); 12–14 seconds (score 2);
10–11 seconds (score 3); and ≤9 seconds (score 4). An
advantage for the use of categorisation is the inclusion of
persons who could not perform one of the tests (these persons
were assigned a score 0). Each performance test resulted in
a score ranging from 0 to 4. As was done in previous studies,
summing the scores of the three tests for each respondent
provided an overall performance score [20, 23]. A lower
score indicates a poorer physical function. The predictive
validity of the performance score has been established as it
predicts nursing home admission, mortality, hospitalisation,
and subsequent disability [20, 23]. For descriptive purposes
absolute change in performance was computed by subtracting
the follow-up overall performance score from the baseline
overall performance score. 
Other potential determinants 
Baseline variables were selected if they were potential con-
founders. Age was used as a continuous variable. Self-reported
life-style variables included education (low, middle (reference)
and high), smoking (never (reference), former and current),
alcohol consumption (none (reference), >0 to <2 drinks
daily, ≥2 drinks daily), body mass index (BMI; weight/
height2; ≤25, 25–30 (reference), ≥30 in kg/m2) and physical
activity (tertiles). Physical activity (minutes per day) during
the past 2 weeks was based on the following activities: walk-
ing outdoors, cycling, light and heavy household activities,
and a maximum of two sport activities. Disease-related variables
included self-reports of the presence of diabetes mellitus,
heart disease, CVA, pulmonary disease (asthma or chronic
obstructive pulmonary disease), arthritis (osteoarthritis or
rheumatoid arthritis), cancer, peripheral artery disease
(PAD), depressive symptoms and cognitive function. For
depressive symptoms the Center for Epidemiologic Studies
Depression (CES-D) Scale was used [24], and a score of
≥16 was used to indicate depression [25]. Cognitive func-
tioning was measured with the Mini-Mental State Examination
(MMSE), and a score of ≤23 was used to indicate cognitive
impairment [26]. Missing values for height and weight were
replaced by self-reported measurements at baseline for
height (n = 8) and weight (n = 10) or at the 3-year follow-up
(n = 5). Missing values for MMSE (n = 6) and CES-D (n = 3)
were replaced by values obtained at the 3-year follow-up.
When missing values were not imputed, the analyses produced
highly similar results. 
Statistical analyses 
Analyses were performed using SPSS 9.0 as a statistical pack-
age. The outcome variable of interest was 3-year change in
functional performance, and was calculated according to the
Edwards-Nunnally index method (EN-index) [27, 28]. This
method was used in previous studies [29] in the context of
LASA. It takes regression to the mean into account. This
was necessary because regression to the mean was present
in the study sample (data not shown). Using this method we
compare each measurement on baseline and 3-year follow-
up per individual. The EN-index was computed from the
reliability of the overall performance score at baseline
(α = 0.64) and the 90% CI (90% CI ± 1.645 × standard
error (se)) of the mean score at baseline (M = 7.86, se = 1.60).
[If T2<(α × (T1 – M) + M – 1.645 ×se) EN-index = decline;
if T2≥ (α× (T1–M)+M–1.645×se) and T2≤ (α× (T1–M)+
M + 1.645 ×se) or if T2 > (α × (T1 – M) + M + 1.645 ×se))
EN-index = no decline; se =SD* (extract the root of (1 – α)),
where T1 = score at baseline, T2 = score at 3-year follow-up,
α = reliability on T1, M = mean score at T1, SD = standard
deviation on T1 and SE = standard error.] A signiWcant
change requires that the 3-year follow-up score is not
included in the 10% CI. The 3-year change in functional
performance, based on the EN-index, was categorised into
two categories: decline versus no decline. 
Preliminary analyses showed different results for men
and women, which was conWrmed by a P-value of <0.10 for
the interaction of albumin and gender, and combined albumin
and total cholesterol with gender with respect to the outcome
of decline in functional performance. Therefore, all analyses
were performed separately for men and women. 
Preliminary analyses also showed that for persons with
high cholesterol levels the risk was similar to that of
persons with intermediate cholesterol levels. This justiWed
the decision to dichotomise the cholesterol variable, using
cut-off points that had previously been reported in the
literature. 
We Wrst compared the baseline characteristics between
men and women using Student’s t-test and Chi-square statistics.
We used the Chi-square test to analyse the relationship of
serum albumin concentrations and total cholesterol concen-
tration with 3-year decline in functional performance. To
investigate the relationship of serum albumin concentration
and total cholesterol concentration, separately and combined,
with 3-year decline in functional performance, multiple
logistic regression analysis was used (P-values were based
on the Wald-test). Results are presented as odds ratios (OR)
with 95% CI. Baseline variables were included in three suc-
cessive models to provide insight into potential confounders.
In model 1, baseline performance score and age were
included. In model 2, mainly life-style factors were included,
i.e. education, smoking, physical activity, alcohol consumption
and BMI. In the Wnal model, disease-related factors, including
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arthritis, cancer, PAD, CES-D and MMSE score were addi-
tionally included. 
Results 
The characteristics of the study sample are presented in
Table 1. Compared with women, men were more likely to
smoke, more often consumed two or more drinks of alcohol
daily, were less obese, were less depressed, had a higher level of
education, a lower level of physical activity, and a higher preva-
lence of CVA and heart disease. The mean values of the base-
line performance score, the follow-up performance score and
the absolute 3-year change in performance score did not differ
between men and women. More men (18.1%) than women
(7.8%) had a lower serum total cholesterol concentration
(≤5.2 mmol/l). Albumin levels were similar in men and women. 
Appendix 2 (available as supplementary data) presents
the percentages and absolute numbers of men and women
with 3-year decline in functional performance according to
baseline serum albumin (g/l) and total cholesterol (mmol/l)
concentration. A decline in functional performance was
observed more often in men with lower serum albumin con-
centration (22.1%) than in men with higher serum albumin
concentration (13.2%, P=0.01). In women these percentages
did not differ (16.9% and 17.9%, respectively, P = 0.75). In
women a slight difference (P = 0.08) was found between
lower and higher serum total cholesterol concentrations and
functional decline. More women with lower total cholesterol
(27.9%) showed a decline compared to women with higher
serum total cholesterol (16.8%), while in men no difference
was found (P = 0.46). 
Only 12 women (2.2%) and 22 men (4.3%) had lower levels
of both albumin and total cholesterol. Men with lower serum
albumin and lower serum total cholesterol showed decline
more often (31.8%) compared to men with high levels of both
markers (13.3%) (P<0.10). Although in women a trend similar
to men was noted, no signiWcance was found (P>0.10). 
Table 2 shows the results of multiple logistic regression
analysis of the association of 3-year decline in functional
performance with baseline serum albumin and total cholesterol
concentration in men and women in three models. After
adjustment, decline in functional performance was not asso-
ciated with albumin concentration in men and women. Sim-
ilarly, no signiWcant association was found between serum
total cholesterol concentration and decline in functional
performance in men. However, women with lower serum
total cholesterol concentrations were more likely to decline
in functional status compared to women with higher serum
Table 1. Characteristics of participants in the Longitudinal Aging Study Amsterdam 
Differences between men and women were tested with the Student t-test or the Chi-square test. 
BMI = body mass index; CVA = cerebrovascular accident; PAD = peripheral artery disease; CES-D = Center for Epidemiologic Studies Depression Scale;
MMSE = Mini-Mental State Examination. 
*Missing data for education 1, BMI 5, physical activity 8, smoking 2, no of chronic diseases (CVA, diabetes, heart disease, arthritis, PAD, cancer and pulmonary
disease) 2, CES-D 1, MMSE 2.
 Women 
(n = 549) 
Men 
(n = 515) 
Total 
(n = 1064)  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Age, years, mean (interquartile range) 68.0 (61.2–74.7) 68.9 (62.1–76.1) 68.5 (61.5–75.4)
Education*, N (%) Low 363 (66.2) 266 (51.7) 629 (59.2) 
BMI (kg/m2)*, N (%)
≤25 167 (30.6) 192 (37.4) 359 (33.9) 
25–30 230 (42.1) 265 (51.7) 495 (46.7) 
≥30 149 (27.3) 56 (10.9) 205 (19.4) 
Physical activity (min/day)*, N (%)
Low (<108.5) 105 (19.3) 236 (46.0) 341 (32.3) 
Smoking *, N (%)
Never 294 (53.6) 40 (7.8) 334 (31.5) 
Former 166 (30.3) 311 (60.5) 477 (44.9) 
Current 88 (16.1) 163 (31.7) 251 (23.6) 
Alcohol consumption (per day)*, N (%)
None 76 (13.8) 24 (4.7) 100 (9.4) 
>0–<2 drinks 257 (46.8) 133 (25.8) 390 (36.7) 
≥2 drinks 216 (39.3) 358 (69.5) 574 (53.9) 
Number of chronic diseases, N (%) 52 (9.5) 55 (10.7) 107 (10.1) 
CES-D, depressed (≥16)*, N (%) 89 (16.2) 38 (7.4) 127 (11.9) 
MMSE, cognitive impaired (≤23), N (%) 32 (5.9) 30 (5.8) 62 (5.8) 
Baseline performance score, mean (sd) 7.89 (2.81) 7.82 (2.54) 7.85 (2.68) 
3-year performance score, mean (sd) 7.35 (2.93) 7.47 (2.67) 7.41 (2.80) 
Change in performance score, mean (sd) –0.54 (2.36) –0.35 (2.35) –0.45 (2.36) 
Albumin, g/l, N (%)
≤43 130 (23.7) 113 (21.9) 243 (22.8) 
>43 419 (76.3) 402 (78.1) 821 (77.2) 
Cholesterol, mmol/l, N (%)
≤5.2 43 ( 7.8) 93 (18.1) 136 (12.8) 
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total cholesterol (reference) after adjustment for life-style
factors (OR = 2.38; 95% CI 1.05–5.42) and for disease-
related factors (OR = 2.50; 95% CI 1.07–5.84). 
Table 3 shows the association between combined con-
centrations of serum albumin and total cholesterol and
decline in functional performance in three models. Men
with lower serum albumin and lower serum total cholesterol
concentrations were three times more likely to decline in
functional performance compared to men with higher levels,
after adjustment for all potential confounders (OR = 3.00;
95% CI 1.00–8.97). In women, the adjusted OR was 1.73
(95% CI 0.34–8.94), but not statistically signiWcant. 
Discussion 
This prospective study of older men and women provides
insight into the relationship of two frailty markers, serum
albumin and total cholesterol concentration, with 3-year
change in functional performance. The postulated relationship
between lower serum albumin concentration and decline in
functional performance was not found in men or women.
Women with lower total cholesterol had a greater decline in
functional status compared to women with higher serum
total cholesterol. This association was not observed in men.
Men, but not women, with combined lower serum albumin
and lower serum total cholesterol concentration were three
times more likely to decline in functional status compared
to men with higher levels of both markers. 
Previous studies which examined the association of serum
albumin and total cholesterol levels with functional status
were performed among older disabled residents living in nurs-
ing homes [10, 12] and among older high-functioning commu-
nity-dwelling older persons [11, 13]. To our knowledge, our
study is the Wrst prospective study among population-based
Table 2. Associations between baseline serum albumin and total cholesterol concentration and 3-year decline in functional
performance for men and women 
Logistic regression using three models, model 1: adjusted for age and performance score at baseline; model 2: additionally adjusted for education, BMI, physical
activity, smoking and alcohol consumption; model 3: additionally adjusted for presence of CVA, diabetes, heart disease, arthritis, PAD, cancer and pulmonary dis-
ease, MMSE and CES-D. BMI = body mass index; CVA = cerebrovascular accident; PAD = peripheral artery disease; CES-D = Center for Epidemiologic Studies
Depression Scale; MMSE = Mini-Mental State Examination; OR = odds ratio; CI = conWdence interval. 
*P < 0.10; **P < 0.05.
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .






OR (95% CI) 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Albumin (g/l)
Women
≤43 0.73 (0.42–1.27) 0.71 (0.40–1.28) 0.68 (0.37–1.25) 
>43 1.00 1.00 1.00 
Men 
≤43 1.33 (0.75–2.34) 1.39 (0.76–2.53) 1.49 (0.80–2.77) 
>43 1.00 1.00 1.00 
Cholesterol (mmol/l)
Women
≤5.2 2.05 (0.97–4.36)* 2.38 (1.05–5.42)** 2.50 (1.07–5.84)**
>5.2 1.00 1.00 1.00 
Men 
≤5.2 1.02 (0.55–1.91) 1.17 (0.61–2.25) 1.17 (0.60–2.29) 
>5.2 1.00 1.00 1.00 
Table 3. Associations between combined serum albumin and total cholesterol concentrations and 3-year decline in functional
performance for men and women 
Logistic regression using three models, model 1: adjusted for age and performance score at baseline; model 2: additionally adjusted for education, BMI, physical
activity, smoking and alcohol consumption; model 3: additionally adjusted for presence of CVA, diabetes, heart disease, arthritis, PAD, cancer and pulmonary dis-
ease, MMSE and CES-D. BMI = body mass index; CVA = cerebrovascular accident; PAD = peripheral artery disease; CES-D = Center for Epidemiologic Studies
Depression Scale; MMSE = Mini-Mental State Examination; OR = odds ratio; CI = conWdence interval. 
*P < 0.10; **P < 0.05.
 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .






OR (95% CI) 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Women: albumin and cholesterol    
≤43 (g/l) and ≤5.2 (mmol/l) 2.06 (0.56–7.58) 2.14 (0.46–10.01) 1.73 (0.34–8.94)
>43 (g/l) and >5.2 (mmol/l) 1.00 1.00 1.00
Men: albumin and cholesterol
≤43 (g/l) and ≤5.2 (mmol/l) 1.97 (0.72–5.41) 2.54 (0.87–7.43)* 3.00 (1.00–8.97)**
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older men and women on the relation between combined
serum albumin and total cholesterol concentration and 3-year
decline in functional status that adjusts for several potential
confounders. Furthermore, we measured functional status
using performance tests instead of using (self-)reported func-
tional status. Another strength of our study is the use of the
EN-index to determine relevant change in functional status. 
Deterioration in functional status (disability) has been
found to be associated with serum albumin [10] and serum
total cholesterol [12] separately. However, in our study no
association with serum albumin was found. Therefore,
either the speciWc population or the use of self-reports
instead of performance tests for functional status might
explain the observed relationship between low albumin and
functional decline [10]. In another study an association was
found between combined serum albumin and total cholesterol
and decline in functional status [13]. However, these results
were unadjusted for chronic diseases such as coronary heart
disease (CHD), CVA or arthritis. Acute and chronic diseases
are associated with inXammation [6, 30] and the release of
inXammatory cytokines such as interleukin-1, interleukin-6,
and tumor necrosis factor α [31]. These cytokines induce an
acute-phase response, which causes a decrease in serum
albumin, and may result in hypoalbuminaemia [6, 31–33]. In
addition, inXammatory cytokines may also cause hypochol-
esterolaemia [30, 32]. Furthermore, the presence of chronic
diseases, such as CVA, CHD and arthritis, has been found
to cause decline in functional status [34]. Thus, chronic diseases
may lead to a decrease in serum albumin, total cholesterol
and functional status. Nevertheless, in our study we
adjusted for life-style and disease-related factors and found
a three times increased risk for combined lower levels of
serum albumin and total cholesterol with decline in func-
tional status in men. Both albumin and total cholesterol are
synthesised in the liver, and deterioration of the liver function
might be attributable to changes in serum albumin concen-
tration or total cholesterol concentration [6, 35, 36]. It has
been suggested that an overall deterioration in the liver
function might be associated with a poor health status, and
might therefore contribute to a decline in functional status [36]. 
Different results were observed for men and women.
Women have generally higher total cholesterol levels com-
pared to men [37], which was also found in our study sample.
Thus, there are relatively more women with high serum total
cholesterol levels in the reference group, which may have led
to the stronger associations in women. When the frailty mark-
ers were combined, a signiWcant result occurred only in men.
A similar trend was found for women, although not signiW-
cant. Due to the low number of women, when serum albumin
and total cholesterol levels were combined, the statistical
power to detect signiWcant differences may have been too low. 
Possible limitations of the study should be addressed.
The cut-off point for lower serum albumin was rather high.
Generally, the cut-off point for hypoalbuminaemia is <35 g/l
and for low albumin <38 g/l, but in our population-based
study only one person had a serum albumin level lower than
38 g/l. The cut-off point for low serum total cholesterol is
generally 4.1 mmol/l. Again, very few persons had levels
below 4.1 mmol/l. The relatively high cut-off point for
lower albumin and lower serum total cholesterol may have
resulted in an underestimation of the association between
albumin and functional decline. Another potential limitation
of the study is that both serum albumin and total cholesterol
were measured in two different laboratories. Nevertheless
the interaction terms laboratory*serum albumin and labora-
tory*serum total cholesterol were not statistically signiWcant
(P-value > 0.50), suggesting that the associations under
study were similar for both laboratories. A further limitation
of the present study is that a substantial number of respondents
had to be excluded from the initial sample. Those excluded
from the present study had a poorer health status, lower
albumin levels and poorer performance. Therefore it should
be kept in mind that the present Wndings might not be
extrapolated to frail older persons. The observed associations
are likely to be underestimated. A Wnal limitation of this
study is that blood samples were taken in a non-fasting
state, which might inXuence the concentration of serum
albumin and cholesterol. This might have resulted in an
underestimation of the observed associations. 
In conclusion, no association was found between lower
serum albumin and functional decline in men and women.
Lower serum total cholesterol was associated with an increased
risk in functional decline in women only. Combined lower
serum albumin and lower total cholesterol levels were associ-
ated with an increased risk of deterioration in functional status,
although this association was statistically signiWcant only in
men. Whether or not the cut-off points for serum albumin and
total cholesterol used in this study could be used for diagnostics
remains to be investigated with diagnostic research. Combining
these frailty markers may be an important tool for detecting
older persons who are at risk for future functional decline. 
Key points 
• Lower serum albumin was not associated with future
decline in functional performance in older men and
women. 
• Lower total cholesterol was associated with future
decline in functional performance in women only. 
• A combination of lower serum albumin and lower total
cholesterol was associated with a decline in functional
performance in men. In women a similar trend was
found, although not statistically signiWcant. 
• Combining these blood markers might be an important tool
for detecting older persons at risk for functional decline. 
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